Rp Pharmaverve Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -99.51%
- Profit Growth 82.96%
- Ebitda 100.00%
- Net Worth -13.45%
- Total Assets -37.32%
About Rp Pharmaverve
Rp Pharmaverve Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 March 2014 and has a history of Ten years and 11 months. Its registered office is in Hisar, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Puneet Maini and Arnav Maini serve as directors at the Company.
Company Details
-
Location
Hisar, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U93000HR2014PTC052046
-
Company No.
052046
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Mar 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Rp Pharmaverve?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Puneet Maini
|
Director | 04-Mar-2014 | Current |
|
Arnav Maini
|
Director | 05-May-2020 | Current |
Financial Performance of Rp Pharmaverve.
Rp Pharmaverve Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.51% decrease. The company also saw a substantial improvement in profitability, with a 82.96% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rp Pharmaverve?
Unlock access to Rp Pharmaverve's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Martin & Brown Bio-Sciences Private LimitedPuneet Maini is a mutual person
-
Howthorn Biotech Private Limited
Puneet Maini is a mutual person
-
Nicolle & Morse Technologies Private Limited
Puneet Maini and Arnav Maini are mutual person
-
Vetpure Wellness Healthcare Private Limited
Puneet Maini is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rp Pharmaverve?
Unlock and access historical data on people associated with Rp Pharmaverve, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rp Pharmaverve, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rp Pharmaverve's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
